Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy

Version 1 : Received: 8 December 2023 / Approved: 8 December 2023 / Online: 11 December 2023 (10:17:52 CET)

A peer-reviewed article of this Preprint also exists.

Turkalj, M.; Miletić Gospić, A.; Višekruna Džidić, I.; Banić, I. Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy. Medicina 2024, 60, 121. Turkalj, M.; Miletić Gospić, A.; Višekruna Džidić, I.; Banić, I. Food Allergen Immunotherapy in the Treatment of Patients with IgE-Mediated Food Allergy. Medicina 2024, 60, 121.

Abstract

The prevalence of allergic diseases, including food allergy, is increasing, especially in developed countries. Implementation of an elimination diet is not a sufficient therapeutic strategy in patients with food allergy, whose quality of life is significantly impaired. In recent years, new effective therapeutic strategies have been developed, such as the application of oral, sublingual, and epicutenous immunotherapy. Oral immunotherapy is the most often applied strategy because of its effectiveness and ease of application, with an acceptable safety profile. The effectiveness of oral immunotherapy in patients with egg, cow's milk and peanut allergy has been proven both in terms of raising of the threshold and the development of tolerance, and in some patients, the development of sustainable unresponsiveness. Although oral immunotherapy is an effective treatment for food allergy, several limitations, including long duration and a significant rate of reported adverse events, reduces its success. Therefore, new therapeutic options, such as treatment with biologicals, either as combinations with food allergen immunotherapy or as monotherapy with the aim of improving the efficacy and safety of treatment are being investigated..

Keywords

food allergy, IgE mediated food allergy, oral immunotherapy, OIT, sublingual immunotherapy, SLIT, epicutaneous immunotherapy, EPIT, biologics

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.